EGFR expression in gallbladder carcinoma in North America.
about
Targeted Therapy in Biliary Tract CancersOverexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer.A genetic model for gallbladder carcinogenesis and its dissemination.Therapeutic effects of long-circulating miR-135a-containing cationic immunoliposomes against gallbladder carcinoma.Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma.Evaluation of P53, E-cadherin, Cox-2, and EGFR protein immunoexpression on prognostic of resected gallbladder carcinoma.Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers.Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.The role of epidermal growth factor receptor in cancer metastasis and microenvironment.Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer.HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?Significance of epithelial growth factor in the epithelial-mesenchymal transition of human gallbladder cancer cells.Mutational frequency of KRAS, NRAS, IDH2, PIK3CA, and EGFR in North Indian gallbladder cancer patients.EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.Prognostıc value of increased HER2 expression in cancers of pancreas and biliary tree.Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.[Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma].
P2860
Q26798443-348ADBE0-19EA-4C39-B95B-E670F6AA7AD5Q33557258-FFCAC4C8-BD9B-483A-B473-80CFC062BCCAQ33683102-B445490C-3AD4-4286-A584-1BFBF66753D5Q33921112-B11B8342-1FA5-4260-94A7-C588F04CEE9DQ34180209-FB38AC7E-D544-4CAD-92A6-1951A6A6E179Q36370528-C5BB2041-D367-4CF5-9EB2-C7E5044EFAF3Q36677934-ECA5412F-33AC-4D3A-A69E-E44BAC237873Q37215137-2CE4100E-1D51-428F-B0F0-1CFF04F9C972Q38132400-24D03BC1-88BB-46F0-8FBC-5FA2C255993BQ38993903-5E27F8FE-7201-4748-96F0-0D4AB62D6ADAQ39040859-82B2C7C3-37B6-40BE-A826-17AEEDD2136FQ39382611-AE68BEEB-4D01-4C2E-8530-1F2B256C4185Q41545847-35946FD9-C3DC-46F9-98B9-E3D679E2864CQ45871350-E90D1358-BD3E-474E-B7F7-5B2605787271Q51075580-080F32DE-786D-4634-BE95-5D9E3B15EAE4Q54117757-470C91D4-DBE9-4D88-A284-D0A0F2502684Q54222781-1AE02515-2123-454B-B70B-D35EACB25753Q54493763-22563AF2-9E65-4914-AF9C-4D730508C822
P2860
EGFR expression in gallbladder carcinoma in North America.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
EGFR expression in gallbladder carcinoma in North America.
@ast
EGFR expression in gallbladder carcinoma in North America.
@en
type
label
EGFR expression in gallbladder carcinoma in North America.
@ast
EGFR expression in gallbladder carcinoma in North America.
@en
prefLabel
EGFR expression in gallbladder carcinoma in North America.
@ast
EGFR expression in gallbladder carcinoma in North America.
@en
P2093
P2860
P356
P1476
EGFR expression in gallbladder carcinoma in North America.
@en
P2093
Adrienne Thomas
Alexander Fuchs
Bhoomi Mehrotra
Matthew Kaufman
Sandy Nissel-Horowitz
Sewanti Limaye
Sherrie White
Yehuda Lebowicz
P2860
P304
P356
10.7150/IJMS.5.285
P407
P577
2008-09-22T00:00:00Z